CKAP2L, as an Independent Risk Factor, Closely Related to the Prognosis of Glioma
Authors:
Open Access
- 1 January 2021
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2021 (1)
Abstract
Recent studies have found that cytoskeleton‐associated protein 2 like (CKAP2L), an important oncogene, is involved in the biological behavior of many malignant tumors, but its function in the malignant course of glioma has not been confirmed. The main purpose of this study was to clarify the relationship between prognostic clinical characteristics of glioma patients and CKAP2L expression using data collected from the GEPIA, HPA, CGGA, TCGA, and GEO databases. CKAP2L expression was significantly increased in glioma. Further, Kaplan‐Meier plots revealed that increased expression of CKAP2L was associated with shorter survival time of glioma patients in datasets retrieved from multiple databases. Cox regression analysis indicated that CKAP2L can serve as an independent risk factor but also has relatively reliable diagnostic value for the prognosis of glioma patients. The results of gene set enrichment analysis suggested that CKAP2L may play a regulatory role through the cell cycle, homologous recombination, and N‐glycan biosynthesis cell signaling pathways. Several drugs with potential inhibitory effects on CKAP2L were identified in the CMap database that may have therapeutic effects on glioma. Finally, knockdown of CKAP2L inhibited the proliferation and invasion of cells by reducing the expression level of cell cycle‐related proteins. This is the first study to demonstrate that high CKAP2L expression leads to poor prognosis in glioma patients, providing a novel target for diagnosis and treatment of glioma.Keywords
This publication has 33 references indexed in Scilit:
- Radmis, a Novel Mitotic Spindle Protein that Functions in Cell Division of Neural ProgenitorsPLOS ONE, 2013
- The Definition of Primary and Secondary GlioblastomaClinical Cancer Research, 2013
- NCBI GEO: archive for functional genomics data sets—updateNucleic Acids Research, 2012
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2005-2009Neuro-Oncology, 2012
- Pathway-Specific Analysis of Gene Expression Data Identifies the PI3K/Akt Pathway as a Novel Therapeutic Target in Cervical CancerClinical Cancer Research, 2012
- Oncogene- and tumor suppressor gene-mediated suppression of cellular senescenceSeminars in Cancer Biology, 2011
- NCBI GEO: archive for functional genomics data sets--10 years onNucleic Acids Research, 2010
- Oxidative stimuli-responsive nanoprodrug of camptothecin kills glioblastoma cellsBioorganic & Medicinal Chemistry Letters, 2010
- Molecular Imaging of N-linked Glycosylation Suggests Glycan Biosynthesis Is a Novel Target for Cancer TherapyClinical Cancer Research, 2010
- The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and DiseaseScience, 2006